Abstract
Mucopeptide, isolated from the cell wall of streptococcus, when injected into rats induces a dose-dependent hyperthermia. Simultaneously a profound disturbance of deep sleep occurs, which appears to be indirectly related to the magnitude of the fever. A monoamine oxidase inhibitor (pargyline) induces a hypothermia in control animals and reverses the fever caused by mucopeptide. Under the influence of pargyline the EEG patterns are changed to that of wakefulness, an effect lasting several hours. At the height of fever, two hr after mucopeptide administration, the turnover rate of hypothalmic 5-hydroxytryptamine is doubled.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
